×
About 58,454 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  28,067 results

Differentiated cells in prolonged hypoxia produce highly infectious native-like hepatit...
https://doi.org/10.1002/hep.31788
Hepatology (Baltimore, Md.); Cochard J, Bull-Maurer A et. al.

Mar 5th, 2021 - Standard Hepatitis C virus (HCV) cell culture models present an altered lipid metabolism and thus produce lipid-poor lipo-viral-particles (LVPs). These models are thereby weakly adapted to explore the complete natural viral life cycle. To overcome...

Willingness to Participate in Research among Black Patients with Liver Disease: A Natio...
https://doi.org/10.1111/jvh.13493
Journal of Viral Hepatitis; McGuire FH, André K et. al.

Mar 5th, 2021 - In the United States, Black people are disproportionately diagnosed with hepatitis C virus (HCV) compared to White people but are under-represented in HCV studies. In this US-based cross-sectional telephone survey study, we assessed willingness to...

Attitudes toward pharmacy-based HCV/HIV testing among people who use drugs in rural Ken...
https://doi.org/10.1111/jrh.12564
The Journal of Rural Health : Official Journal of the Ame... Duong M, Delcher C et. al.

Mar 5th, 2021 - Rural areas of the United States have experienced outbreaks of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections among people who use drugs (PWUD). Pharmacy-based interventions may play a crucial role in prevention and entr...

Factors associated with treatment failure of direct-acting antivirals for chronic hepat...
https://doi.org/10.1111/liv.14849
Liver International : Official Journal of the Internation... Chen CY, Huang CF et. al.

Mar 3rd, 2021 - Direct-acting antivirals (DAAs) are highly effective in treating chronic hepatitis C virus (HCV)-infected patients. The real-world treatment outcome in Taiwanese patients on a nationwide basis is elusive. The Taiwan HCV Registry (TACR) program is ...

N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediat...
https://doi.org/10.1073/pnas.2022024118
Proceedings of the National Academy of Sciences of the Un... Kim GW, Siddiqui A

Mar 2nd, 2021 - Hepatitis C virus (HCV) infections are associated with the risk of progression to fibrosis, cirrhosis, and hepatocellular carcinoma. The HCV RNA genome is translated by an internal ribosome entry site (IRES)-dependent mechanism. The structure and ...

see more →

Guidelines  51 results

Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.
https://doi.org/10.1053/j.gastro.2020.09.065
Gastroenterology Rockey DC, Friedman SL

Feb 2nd, 2021 - Hepatitis C virus (HCV) infection and its complications have been the major cause of cirrhosis and its complications for several decades in the Western world. Until recently, treatment for HCV with interferon-based regimens was associated with mod...

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 23rd, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  29,015 results

Differentiated cells in prolonged hypoxia produce highly infectious native-like hepatit...
https://doi.org/10.1002/hep.31788
Hepatology (Baltimore, Md.); Cochard J, Bull-Maurer A et. al.

Mar 5th, 2021 - Standard Hepatitis C virus (HCV) cell culture models present an altered lipid metabolism and thus produce lipid-poor lipo-viral-particles (LVPs). These models are thereby weakly adapted to explore the complete natural viral life cycle. To overcome...

Willingness to Participate in Research among Black Patients with Liver Disease: A Natio...
https://doi.org/10.1111/jvh.13493
Journal of Viral Hepatitis; McGuire FH, André K et. al.

Mar 5th, 2021 - In the United States, Black people are disproportionately diagnosed with hepatitis C virus (HCV) compared to White people but are under-represented in HCV studies. In this US-based cross-sectional telephone survey study, we assessed willingness to...

Attitudes toward pharmacy-based HCV/HIV testing among people who use drugs in rural Ken...
https://doi.org/10.1111/jrh.12564
The Journal of Rural Health : Official Journal of the Ame... Duong M, Delcher C et. al.

Mar 5th, 2021 - Rural areas of the United States have experienced outbreaks of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections among people who use drugs (PWUD). Pharmacy-based interventions may play a crucial role in prevention and entr...

Factors associated with treatment failure of direct-acting antivirals for chronic hepat...
https://doi.org/10.1111/liv.14849
Liver International : Official Journal of the Internation... Chen CY, Huang CF et. al.

Mar 3rd, 2021 - Direct-acting antivirals (DAAs) are highly effective in treating chronic hepatitis C virus (HCV)-infected patients. The real-world treatment outcome in Taiwanese patients on a nationwide basis is elusive. The Taiwan HCV Registry (TACR) program is ...

N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediat...
https://doi.org/10.1073/pnas.2022024118
Proceedings of the National Academy of Sciences of the Un... Kim GW, Siddiqui A

Mar 2nd, 2021 - Hepatitis C virus (HCV) infections are associated with the risk of progression to fibrosis, cirrhosis, and hepatocellular carcinoma. The HCV RNA genome is translated by an internal ribosome entry site (IRES)-dependent mechanism. The structure and ...

see more →

News  1,285 results

HCV Declines Level Off in HIV+ Men Who Have Sex With Men
https://www.medscape.com/viewarticle/943804

Jan 10th, 2021 - NEW YORK (Reuters Health) - The incidence of hepatitis C virus (HCV) infection among HIV-positive men who have sex with men in the Netherlands fell once direct-acting antivirals (DAAs) became universally available in 2015, new findings show. While...

One-Year Transplant Outcomes Similar With Kidneys From HCV+, HCV- Donors
https://www.medscape.com/viewarticle/942667

Dec 15th, 2020 - NEW YORK (Reuters Health) - Outcomes for renal transplants from hepatitis C virus (HCV)-infected donors to HCV-negative recipients are similar to those for HCV-negative patients who receive kidneys from donors without HCV, according to a one-year ...

Patients Cured of HCV Still at High Liver Cancer Risk
https://www.medscape.com/viewarticle/941615

Nov 25th, 2020 - NEW YORK (Reuters Health) - The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests. "The new hep...

Combo DAA Treatments May Benefit Patients With Resistant HCV Genotype 3
https://www.medscape.com/viewarticle/941464

Nov 22nd, 2020 - Patients with hepatitis C virus (HCV) genotype 3 infection have shown resistance to direct-acting antiviral (DAA) treatments. However, a meta-analysis of 34 research reports found that DAA combo treatment can be effective in achieving sustained vi...

Opt-Out Policy at a Syringe Service Program Increased HIV/HCV Testing
https://www.staging.medscape.com/viewarticle/941269

Nov 18th, 2020 - Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program. Researchers conducted a retrospective comparative analysis o...

see more →

Patient Education  3 results see all →